Innovative therapeutics

Investors

SEC Filings

NASDAQBMRN
FormDescriptionDateFormat
CORRESPCorrespondence from the Filer to the SECDec 31, 2014View HTMLDownload DOCDownload PDFDownload XLS
SC TO-T/AAmendment to a previously filed SC TO-TDec 31, 2014View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesDec 29, 2014View HTMLDownload DOCDownload PDF
SC TO-T/AAmendment to a previously filed SC TO-TDec 24, 2014View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventDec 23, 2014View HTMLDownload DOCDownload PDFDownload XLS
SC TO-TTender offer schedule and amendment filed by a third party.Dec 12, 2014View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesDec 12, 2014View HTMLDownload DOCDownload PDF
SC TO-CWritten public communication relating to an issuer or third party tender offer not by the subject coDec 10, 2014View HTMLDownload DOCDownload PDFDownload XLS
8-K/AAmendment to a previously filed 8-KDec 10, 2014View HTMLDownload DOCDownload PDFDownload XLS
SC TO-CWritten public communication relating to an issuer or third party tender offer not by the subject coDec 10, 2014View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesDec 8, 2014View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesDec 5, 2014View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesDec 3, 2014View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesDec 2, 2014View HTMLDownload DOCDownload PDF
SC TO-CWritten public communication relating to an issuer or third party tender offer not by the subject coDec 1, 2014View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesNov 28, 2014View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 28, 2014View HTMLDownload DOCDownload PDF
SC TO-CWritten public communication relating to an issuer or third party tender offer not by the subject coNov 26, 2014View HTMLDownload DOCDownload PDFDownload XLS
SC TO-CWritten public communication relating to an issuer or third party tender offer not by the subject coNov 26, 2014View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventNov 26, 2014View HTMLDownload DOCDownload PDFDownload XLS
SC TO-CWritten public communication relating to an issuer or third party tender offer not by the subject coNov 24, 2014View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventNov 24, 2014View HTMLDownload DOCDownload PDFDownload XLS
SC TO-CWritten public communication relating to an issuer or third party tender offer not by the subject coNov 24, 2014View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesNov 14, 2014View HTMLDownload DOCDownload PDF
4/AAmendment to a previously filed 4Nov 14, 2014View HTMLDownload DOCDownload PDF
1-25      26-50      51-75      76-100      101-125      126-137

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information